Allianz Asset Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding UTMD
RHJA
Allianz Asset Management's UTMD Position: Q2 2021 in Review
Allianz Asset Management sold out of Utah Medical Products (UTMD) in Q2 2021, closing a stake of 6,210 shares — an estimated $538K sold.
Allianz Asset Management first reported a position in UTMD in Q4 2017 and held it in 14 quarters. The position peaked at $718K in Q4 2019. 68 funds tracked by Wall St. Rank hold UTMD as of Q2 2021.
- Allianz Asset Management reported no remaining Utah Medical Products position as of Q2 2021 after selling out during the quarter.
- Allianz Asset Management sold 6,210 Utah Medical Products shares in Q2 2021, an estimated $538K.
- Allianz Asset Management first reported a position in Utah Medical Products in Q4 2017 and held it in 14 quarters.
- Allianz Asset Management's Utah Medical Products position peaked at $718K in Q4 2019.
- 68 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2021.
Based on Allianz Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.